AtriCure gets FDA OK for Synergy ablation system

12/19/2011 | Reuters

The FDA has granted AtriCure approval for its Synergy ablation device for use in treating patients with atrial fibrillation during open-heart procedures. The Synergy system is the first such device to have been cleared for atrial fibrillation therapy in the U.S.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Global Medical Safety Director - Transcatheter Heart Valve
Edwards Lifesciences
Irvine, CA
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Compliance Manager/Sr. Compliance Manager- Auditing
Genentech
South San Francisco, CA
Director of Program Development
AdvaMed
Washington DC, DC
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC